24 HR phentermine 3.75 MG / topiramate 23 MG Extended Release Oral Capsule [Qsymia]
RxNorm concept 1302845, branded drug (sbd). Prescribable name: Qsymia 3.75 MG / 23 MG 24HR Extended Release Oral Capsule.
- RxCUI
- 1302845
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1302845 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Qsymia 3.75/23 (phentermine (as hydrochloride) / topiramate) 24 HR Extended Release Oral Capsule; Qsymia 3.75/23 (phentermine / topiramate) 24 HR Extended Release Oral Capsule; Qsymia 3.75/23 24 HR Extended Release Oral Capsule
Related concepts
- phentermine 3.75 MG (SCDC, consists of)
- topiramate 23 MG (SCDC, consists of)
- phentermine 3.75 MG / topiramate 23 MG [Qsymia] (SBDC, consists of)
- Extended Release Oral Capsule (DF, has dose form)
- Qsymia (BN, has ingredient)
- 24 HR phentermine 3.75 MG / topiramate 23 MG Extended Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1302845 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1302845 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1302845. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.